Category Archives: Southland Eye

  • 0
Dr Erica Tritsch

Dr. Lipschultz Welcomes Dr. Erica Tritsch to Southland Eye Associates!

Dr. Lipschultz is proud to announce the addition of Dr. Erica Tritsch to the team at Southland Eye Associates!

Dr. Tritsch joined Southland Eye Associates in summer of 2021. Dr. Tritsch’s practice philosophy begins with developing a strong patient-doctor relationship. She has special interests in diagnosing and managing ocular diseases such as macular degeneration, diabetic retinopathy, and glaucoma, as well as fitting general and specialty contact lenses.

Dr. Tritsch attended Indiana University for her undergraduate education and completed her optometric training at the Illinois College of Optometry, where she graduated with honors. Dr. Tritsch is an active member of the American Academy of Optometry and American Optometric Association.

Dr. Tritsch is originally from Munster, Indiana and is thrilled to return nearby to provide patient care. In her free time, she enjoys running, yoga sculpt, spending time with friends and family-especially playing with her niece Lily, and walking her dogs.


  • 0
contacts from southland eye

New Contact Lens Passes FDA for the Treatment of Myopia

Tags : 

FDA Approves Myopia Control Contact Lens: MiSight

Myopia, also known as nearsightedness, is reaching epidemic levels. Myopia control is the area of vision care dedicated to slowing myopia. Myopia often progresses through early adulthood. It was previously thought that myopia could not be controlled. Research is now showing that nearsightedness may be slowed with the use of some or all of specialized contact lenses, eye drops, and specialized eyeglass lenses. Slowing the progression might lower the final level of nearsightedness reached at adulthood, and can have a huge impact of adult vision disorders associated with nearsightedness such as retinal disease, retinal detachment, and glaucoma.

The new MiSight contact lens is a welcome addition to our treatment options we provide to our patients entering our Myopia Control Program at Southland Eye Associates.

Below is the full press release:

The U.S. Food and Drug Administration today approved the first contact lens indicated to slow the progression of myopia (nearsightedness) in children between the ages of 8 and 12 years old at the initiation of treatment. The MiSight contact lens is a single use, disposable, soft contact lens that is discarded at the end of each day, and is not intended to be worn overnight.

“Today’s approval is the first FDA-approved product to slow the progression of myopia in children, which ultimately could mean a reduced risk of developing other eye problems,” said Malvina Eydelman, M.D., director of the Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices in the FDA’s Center for Devices and Radiological Health.

Myopia is the most frequent cause of correctable visual impairment worldwide. Myopia occurs when the eye grows too long from front to back (axial length). Instead of focusing images on the retina, images are focused at a point in front of the retina. As a result, people with myopia have good near vision, but poor distance vision that can be corrected with glasses or contact lenses.

Myopia is common in children and tends to increase as they get older. If a person develops severe myopia as a child, they may be susceptible to other eye problems such as early cataracts or a detached retina during adulthood. The MiSight soft contact lenses are meant to be worn daily to correct nearsightedness and slow the progression of myopia in children with healthy eyes. When placed on the eye, one part of the MiSight contact lens corrects the refractive error to improve distance vision in nearsighted eyes, similar to a standard corrective lens. In addition, concentric peripheral rings in the lens focus part of the light in front of the retina (the back of the eye). This is believed to reduce the stimulus causing the progression of myopia.

The approval of MiSight was based on data obtained from a prospective clinical trial at four clinical sites and real-world evidence. The safety and effectiveness of MiSight was studied in a three-year randomized, controlled clinical trial of 135 children ages 8 to 12 at the start of treatment who used MiSight or a conventional soft contact lens. The trial showed that for the full three-year period, the progression in myopia of those wearing MiSight lenses was less than those wearing conventional soft contact lenses. In addition, subjects who used MiSight had less change in the axial length of the eyeball at each annual checkup. Over the course of the trial, there were no serious ocular adverse events in either arm of the study.

Additionally, to estimate the rate of vision-threatening corneal infections (i.e., corneal ulcers) among children and adolescents who wear soft contact lenses daily, the FDA reviewed real world data from a retrospective analysis of medical records of 782 children ages 8 to 12 years old from seven community eye care clinics. The results showed a rate comparable to the rate of ulcer cases among adults who wear contact lenses daily.

As part of the approval of MiSight, the sponsor is required to conduct a postmarket study of the contact lenses to further evaluate the safety and effectiveness of the product as indicated.

The FDA granted approval of MiSight to CooperVision Inc. The device was approved using the Premarket Approval (PMA) pathway. Premarket approval is the most stringent type of device marketing application required by FDA and is based on a determination by the FDA that the PMA application contains sufficient valid scientific evidence to provide reasonable assurance that the device is safe and effective for its intended use(s).

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.


  • 0

Welcome Dr. Birva K. Shah

Dr. Lipschultz Welcomes Dr. Birva K. Shah to Southland Eye!

Dr. Lipschultz is proud to announce, and welcome, Dr. Birva K. Shah to the practice, beginning in the November of 2019.

Dr. Shah is a residency trained optometrist, specializing in pediatric and contact lens care. She has extensive experience with binocular vision disorders, including strabismus, amblyopia, and convergence/accommodative disorders.  She also has extensive training in specialty contact lenses, scleral contact lenses, and diagnosis and management of glaucoma, macular degeneration and diabetic eye disease.

Dr. Shah grew up on the western suburbs of Chicago, attended the Illinois College of Optometry in Chicago, is married, and has one lovely daughter.


  • 0
november southland eye giveaway

Enroll in our November $1000 Giveaway!

Tags : 

Enroll in our $1000 of FREE OPTICAL in our November Giveaway! It’s our way of saying THANK YOU to our many patients!

Glasses for yourself or family members? Sunglasses for everyone? Whatever you need!

There are no costs to enroll! Then, once you’re enrolled, you’ll receive brief instructions as to how you can receive additional chances to win by following on social media like Facebook or Instagram, or by telling friends about the Giveaway.

Enrollment closes November 17th 2017 at 5pm central time! Enroll Now!

 


  • 0
back to school savings

Back To School Eye Exams

Tags : 

It’s hard to believe it, but it’s back to school time. Yep. time for trips to grab school supplies, clothes, and much more. But Don’t forget the back to school eye exams!

Check out our back to school deals on optical, contacts and more on our Back to School page!